Assessing the efficacy and safety of rheumatic disease treatments: Obstacles and proposed solutions

Arthritis and Rheumatism

Volumn 48, Issue 7, 2003, Pages 1781-1787

  Felson, David T ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CHONDROITIN; GLUCOSAMINE; METHOTREXATE;

ANKYLOSING SPONDYLITIS; ARTHRALGIA; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; HUMAN; META ANALYSIS; OSTEOARTHRITIS; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SPONDYLOARTHROPATHY;

ANTIRHEUMATIC AGENTS; CLINICAL TRIALS; HUMANS; RHEUMATIC DISEASES;

EID: 0038681628     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.11087     Document Type: Review

References (33)

1. Peto R, Baigent C. Trials: the next 50 years. Large scale randomised evidence of moderate benefits. BMJ 1998;317:1170-1.
2. Pincus T, Koch GG, Sokka T, Lefkowith J, Wolfe F, Jordan JM, et al. A randomized, double-blind, crossover clinical trial of diclofenac plus misoprostol versus acetaminophen in patients with osteoarthritis of the hip or knee. Arthritis Rheum 2001;44:1587-98.
3. Hill CL, LaValley MP, Felson DT. Secular changes in the quality of published randomized clinical trials in rheumatology. Arthritis Rheum 2002;46:779-84.
4. Moher D, Dulberg CS, Wells GA. Statistical power, sample size, and their reporting in randomized controlled trials. JAMA 1994;272:122-4.
5. Hotopf M, Lewis G, Normand C. Putting trials on trial - the costs and consequences of small trials in depression: a systematic review of methodology. J Epidemiol Community Health 1997;51:1354-8.
6. Dickinson K, Bunn F, Wentz R, Edwards P, Roberts I. Size and quality of randomised controlled trials in head injury: review of published studies. BMJ 2000;320:1308-11.
7. Felson DT. Bias in meta-analytic research. J Clin Epidemiol 1992;45:885-92.
8. Johansen HK, Gotzsche PC. Problems in the design and reporting of trials of antifungal agents encountered during meta-analysis. JAMA 1999;282:1752-9.
9. Sterne JAC, Gavaghan D, Egger M. Publication and related bias in meta-analysis: power of statistical tests and prevalence in the literature. J Clin Epidemiol 2000;53:1119-29.
10. Begg CB, Berlin JA. Publication bias and dissemination of clinical research. J Natl Cancer Inst 1989;81:107-14.
11. McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA 2000;283:1469-75.
12. Roberts I. An amnesty for unpublished trials. BMJ 1998;317:763-4.
13. Assmann SF, Pocock SJ, Enos LE, Kasten LE. Subgroup analysis and other (mis)uses of baseline data in clinical trials. Lancet 2000;355:1064-9.
14. O'Connor CM, Carson PE, Miller AB, Pressler ML, Belkin RN, Neuberg GW, et al. Effect of amlodipine on mode of death among patients with advanced heart failure in the PRAISE trial. Prospective Randomized Amlodipine Survival Evaluation. Am J Cardiol 1998;82:881-7.
15. Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Ann Rheum Dis 1996;55:424-31.
16. Hollis S, Campbell F. What is meant by intention to treat analysis? Survey of published randomised controlled trials [review]. BMJ 1999;319:670-4.
17. Jefferson T. What are the benefits of editorials and non-systematic reviews? BMJ 1999:318:135.
18. Barnes DE, Bero LA. Why review articles on the health effects of passive smoking reach different conclusions. JAMA 1998;279:1566-70.
19. LeLorier J, Gregoire G, Benhaddad A, Lapierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997;337:536-42.
20. Villar J, Piaggio G, Carroli G, Donner A. Factors affecting the comparability meta-analyses and largest trials results in perinatology. J Clin Epidemiol 1997;50:997-1002.
21. McAlister F, Clark H, van Walraven C, Straus S, Lawson F, Moher D, et al. The medical review article revisited: has the science improved? Ann Intern Med 1999;131:947-51.
22. Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996;276:637-9.
23. Moher D, Jones A, Lepage L. Use of the CONSORT statement and quality of reports of randomized trials: a comparative before-and-after evaluation. JAMA 2001;285;1992-5.
24. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357:1191-4.
25. JAMA Web site. Accessed April 28, 2003. URL: www.jama.ama-assn.org/ifora_current.dtl.
26. Felson DT, Anderson JJ, Boers M, Bombardier C, Chernoff M, Fried B, et al. The American College of Rheumatology prelimi-nary core set of disease activity measures for rheumatoid arthritis clinical trials. Arthritis Rheum 1993;36:729-40.
27. Boers M, Tugwell P, Felson DT, van Riel PL, Kirwan JR, Edmonds JP, et al. World Health Organization and International League of Associations for Rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials. J Rheumatol Suppl 1994;41:86-9.
28. Felson DT, Anderson JJ, Boers M, Bombardier C, Furst DD, Goldsmith C, et al. American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis. Arthritis Rheum 1995;38:727-35.
29. Giannini EH, Ruperto N, Ravelli A, Lovell D, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997;40:1202-9.
30. Dougados M, Leclaire P, van der Heijde D, Bloch DA, Bellamy N, Altman RD. Response criteria for clinical trials on osteoarthritis of the knee and hip: a report of the Osteoarthritis Research Society International Standing Committee for Clinical Trials response criteria initiative. Osteoarthritis Cartilage 2000;8:395-403.
31. Anderson JJ, Baron G, van der Heijde D, Felson DT, Dougados M. Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis. Arthritis Rheum 2001;44:1728-9.
32. Davidoff F, DeAngelis CD, Drazen J, Hoey J, Hojgaard L, Horton R, et al. Sponsorship, authorship, and accountability. N Engl J Med 2001;345:825-6.
33. Altman DG. Poor-quality medical research. JAMA 2002;287:2765-7.